Statement of Principles concerning gingivitis (Reasonable Hypothesis) (No. 17 of 2022)
1Statement of Principles concerning gingivitis (Reasonable Hypothesis) (No. 17 of 2022)
Start here
Get a plain-English read of 1
Turn the raw legal text into a practical explanation grounded in Statement of Principles concerning gingivitis (Reasonable Hypothesis) (No. 17 of 2022).
Statement of Principles concerning gingivitis (Reasonable Hypothesis) (No. 17 of 2022)
made under subsection 196B(2) of the
Veterans' Entitlements Act 1986
Compilation No. 1
Compilation date: 21 November 2022
Includes amendments up to: Amendment Statement of Principles concerning gingivitis (Reasonable Hypothesis) (No. 115 of 2022) (F2022L01394)
The day of commencement of this Amendment Statement of Principles concerning gingivitis is 21 November 2022.
About this compilation
This compilation
This is a compilation of the Statement of Principles concerning gingivitis (Reasonable Hypothesis) (No. 17 of 2022) that shows the text of the law as amended and in force on 21 November 2022.
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.
Self‑repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
Contents
1 Name
3 Authority
5 Application
6 Definitions
7 Kind of injury, disease or death to which this Statement of Principles relates
8 Basis for determining the factors
9 Factors that must exist
Section 1 - Statement of Principles concerning gingivitis (Reasonable Hypothesis) (No. 17 of 2022) - Statement of Principles concerning gingivitis (Reasonable Hypothesis) (No. 17 of 2022) | Zoe
10 Relationship to service
11 Factors referring to an injury or disease covered by another Statement of Principles
Schedule 1 - Dictionary
1 Definitions
Endnotes
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
1 Name
This is the Statement of Principles concerning gingivitis (Reasonable Hypothesis) (No. 17 of 2022).
3 Authority
This instrument is made under subsection 196B(2) of the Veterans' Entitlements Act 1986.
5 Application
This instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.
6 Definitions
The terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.
7 Kind of injury, disease or death to which this Statement of Principles relates
(1) This Statement of Principles is about gingivitis and death from gingivitis.
Meaning of gingivitis
(2) For the purposes of this Statement of Principles, gingivitis:
(a) means an acute or chronic inflammation of the gums, limited to the mucosal epithelial tissue overlying the alveolar ridge and surrounding the necks of erupted teeth; and
(b) includes:
(i) acute necrotising ulcerative gingivitis;
(ii) desquamative gingivitis;
(iii) gingival abscess;
(iv) linear gingival erythema;
(v) peri-implant mucositis; and
(vi) plasma cell gingivitis; and
(c) excludes:
(i) destructive gingival inflammation extending beyond the gums into the underlying supporting structures of the teeth;
(ii) gingival hyperplasia and overgrowth;
(iii) gingival recession; and
(iv) oral aphthae.
(3) While gingivitis attracts ICD‑10‑AM code A69.1, K05.0 or K05.1, in applying this Statement of Principles the meaning of gingivitis is that given in subsection (2).
(4) For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.
Death from gingivitis
(5) For the purposes of this Statement of Principles, gingivitis, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's gingivitis.
Note: terminal event is defined in the Schedule 1 - Dictionary.
8 Basis for determining the factors
The Repatriation Medical Authority is of the view that there is sound medical‑scientific evidence that indicates that gingivitis and death from gingivitis can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the MRCA.
Note: MRCA, relevant service and VEA are defined in the Schedule 1 - Dictionary.
9 Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting gingivitis or death from gingivitis with the circumstances of a person's relevant service:
(1) being prevented from cleaning the teeth, including toothbrushing and interdental cleansing, for a continuous period of at least 14 days, within the 30 days before the clinical onset of gingivitis;
(2) having a foreign body embedded in the affected region of the gums at the time of the clinical onset of gingivitis;
Note: Examples of a foreign body embedded in the gums include a fixed orthodontic appliance, an osseointegrated implant or dental prosthesis, particulate materials derived from dental procedures and shrapnel.
(3) having trauma to the affected region of the gums within the 2 weeks before the clinical onset of gingivitis;
Note: trauma to the affected region of the gums is defined in the Schedule 1 - Dictionary.
(4) having direct exposure of the affected area to an irritant substance within the 3 days before the clinical onset of gingivitis;
Note: irritant substance is defined in the Schedule 1 - Dictionary.
(5) having direct exposure of the affected area to an allergen within the 3 days before the clinical onset of gingivitis;
Note: allergen is defined in the Schedule 1 - Dictionary.
(6) having infection with human immunodeficiency virus at the time of the clinical onset of gingivitis;
(7) having chronic renal failure at the time of the clinical onset of gingivitis;
Note: chronic renal failure is defined in the Schedule 1 - Dictionary.
(8) having leukaemia or lymphoma at the time of the clinical onset of gingivitis;
(9) taking a drug that causes neutropenia or agranulocytosis, at the time of the clinical onset of gingivitis;
Note: Examples of drugs that cause neutropenia or agranulocytosis include clozapine, sulfasalazine, ticlopidine and thioamides such as methimazole, carbimazole and propylthiouracil.
(10) having severe vitamin C deficiency at the time of the clinical onset of gingivitis;
Note: severe vitamin C deficiency is defined in the Schedule 1 - Dictionary.
(11) having a solid organ transplant, stem cell transplant or bone marrow transplant before the clinical onset of gingivitis;
(12) being pregnant at the time of the clinical onset of gingivitis;
(13) using the combined oral contraceptive pill as specified for a continuous period of at least the 4 weeks before the clinical onset of gingivitis;
Note: combined oral contraceptive pill as specified is defined in the Schedule 1 - Dictionary.
(14) having an autoimmune or mucocutaneous disease from the specified list of autoimmune or mucocutaneous diseases at the time of the clinical onset of gingivitis;
Note: specified list of autoimmune or mucocutaneous diseases is defined in the Schedule 1 - Dictionary.
(15) having diabetes mellitus at the time of the clinical onset of gingivitis;
(16) having infection involving the affected region of the gums at the time of the clinical onset of gingivitis;
Note: Examples of infections that may involve the gums include tuberculosis, gonorrhoea, syphilis, chickenpox, candidiasis, histoplasmosis, herpes simplex and hand, foot and mouth disease.
(17) experiencing a category 1A stressor or a category 1B stressor within the 14 days before the clinical onset of gingivitis;
Note: category 1A stressor and category 1B stressor are defined in the Schedule 1 - Dictionary.
(18) for acute necrotising ulcerative gingivitis only:
(a) having severe malnutrition at the time of the clinical onset of acute necrotising ulcerative gingivitis;
(b) having smoked tobacco products:
(i) in an amount of at least 2 pack-years before the clinical onset of acute necrotising ulcerative gingivitis; and
(ii) if smoking has ceased before the clinical onset of acute necrotising ulcerative gingivitis, then that onset occurred within 3 months of cessation; or
(c) experiencing a category 2 stressor within the 6 months before the clinical onset of acute necrotising ulcerative gingivitis;
Note 1: A category 2 stressor can arise in a variety of circumstances connected with service. Such circumstances can arise during the course of service, as a result of separation from service and the conditions associated with that separation, and in the transition to civilian life in the years following separation.
Note 2: acute necrotising ulcerative gingivitis, category 2 stressor and one pack-year are defined in the Schedule 1 - Dictionary.
(19) having depressive disorder at the time of the clinical onset of gingivitis;
(20) having drug-induced gingival overgrowth at the time of the clinical onset of gingivitis;
Note: Examples of drugs that cause gingival overgrowth include phenytoin, cyclosporine and calcium channel blockers such as nifedipine, diltiazem and verapamil.
(21) being obese at the time of the clinical onset of gingivitis;
Note: being obese is defined in the Schedule 1 - Dictionary.
(22) being prevented from cleaning the teeth, including toothbrushing and interdental cleansing, for a continuous period of at least 14 days, within the 30 days before the clinical worsening of gingivitis;
(23) having a foreign body embedded in the affected region of the gums at the time of the clinical worsening of gingivitis;
Note: Examples of a foreign body embedded in the gums include a fixed orthodontic appliance, an osseointegrated implant or dental prosthesis, particulate materials derived from dental procedures and shrapnel.
(24) having trauma to the affected region of the gums within the 2 weeks before the clinical worsening of gingivitis;
Note: trauma to the affected region of the gums is defined in the Schedule 1 - Dictionary.
(25) having direct exposure of the affected area to an irritant substance within the 3 days before the clinical worsening of gingivitis;
Note: irritant substance is defined in the Schedule 1 - Dictionary.
(26) having direct exposure of the affected area to an allergen within the 3 days before the clinical worsening of gingivitis;
Note: allergen is defined in the Schedule 1 - Dictionary.
(27) having infection with human immunodeficiency virus at the time of the clinical worsening of gingivitis;
(28) having chronic renal failure at the time of the clinical worsening of gingivitis;
Note: chronic renal failure is defined in the Schedule 1 - Dictionary.
(29) having leukaemia or lymphoma at the time of the clinical worsening of gingivitis;
(30) taking a drug that causes neutropenia or agranulocytosis, at the time of the clinical worsening of gingivitis;
Note: Examples of drugs that cause neutropenia or agranulocytosis include clozapine, sulfasalazine, ticlopidine and thioamides such as methimazole, carbimazole and propylthiouracil.
(31) having severe vitamin C deficiency at the time of the clinical worsening of gingivitis;
Note: severe vitamin C deficiency is defined in the Schedule 1 - Dictionary.
(32) having a solid organ transplant, stem cell transplant or bone marrow transplant before the clinical worsening of gingivitis;
(33) being pregnant at the time of the clinical worsening of gingivitis;
(34) using the combined oral contraceptive pill as specified for a continuous period of at least the 4 weeks before the clinical worsening of gingivitis;
Note: combined oral contraceptive pill as specified is defined in the Schedule 1 - Dictionary.
(35) having an autoimmune or mucocutaneous disease from the specified list of autoimmune or mucocutaneous diseases at the time of the clinical worsening of gingivitis;
Note: specified list of autoimmune or mucocutaneous diseases is defined in the Schedule 1 - Dictionary.
(36) having diabetes mellitus at the time of the clinical worsening of gingivitis;
(37) having infection involving the affected region of the gums at the time of the clinical worsening of gingivitis;
Note: Examples of infections that may involve the gums include tuberculosis, gonorrhoea, syphilis, chickenpox, candidiasis, histoplasmosis, herpes simplex and hand, foot and mouth disease.
(38) experiencing a category 1A stressor or a category 1B stressor within the 14 days before the clinical worsening of gingivitis;
Note: category 1A stressor and category 1B stressor are defined in the Schedule 1 - Dictionary.
(39) for acute necrotising ulcerative gingivitis only:
(a) having severe malnutrition at the time of the clinical worsening of acute necrotising ulcerative gingivitis;
(b) having smoked tobacco products:
(i) in an amount of at least 2 pack-years before the clinical worsening of acute necrotising ulcerative gingivitis; and
(ii) if smoking has ceased before the clinical worsening of acute necrotising ulcerative gingivitis, then that worsening occurred within 3 months of cessation; or
(c) experiencing a category 2 stressor within the 6 months before the clinical worsening of acute necrotising ulcerative gingivitis;
Note 1: A category 2 stressor can arise in a variety of circumstances connected with service. Such circumstances can arise during the course of service, as a result of separation from service and the conditions associated with that separation, and in the transition to civilian life in the years following separation.
Note 2: acute necrotising ulcerative gingivitis, category 2 stressor and one pack-year are defined in the Schedule 1 - Dictionary.
(40) having depressive disorder at the time of the clinical worsening of gingivitis;
(41) having drug-induced gingival overgrowth at the time of the clinical worsening of gingivitis;
Note: Examples of drugs that cause gingival overgrowth include phenytoin, cyclosporine and calcium channel blockers such as nifedipine, diltiazem and verapamil.
(42) being obese at the time of the clinical worsening of gingivitis;
Note: being obese is defined in the Schedule 1 - Dictionary.
(43) inability to obtain appropriate clinical management for gingivitis.
10 Relationship to service
(1) The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.
(2) The factors set out in subsections 9(22) to 9(43) apply only to material contribution to, or aggravation of, gingivitis where the person's gingivitis was suffered or contracted before or during (but did not arise out of) the person's relevant service.
11 Factors referring to an injury or disease covered by another Statement of Principles
In this Statement of Principles:
(1) if a factor referred to in section 9 applies in relation to a person; and
(2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA;
then the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.
Schedule 1 - Dictionary
Note: See Section 6
1 Definitions
In this instrument:
acute necrotising ulcerative gingivitis means a painful and rapidly progressive inflammation of the gums characterised by gingival bleeding with interdental soft tissue necrosis and ulceration.
Note: Acute necrotising ulcerative gingivitis is also known as Vincent gingivitis and trench mouth.
allergen means an antigenic substance capable of producing an immune response.
being obese means:
(a) having a Body Mass Index (BMI) of 30 or greater; or
(b) for males, having a waist circumference exceeding 102 centimetres; or
(c) for females, having a waist circumference exceeding 88 centimetres.
Note: BMI is also defined in the Schedule 1 - Dictionary.
BMI means W/H2 where:
(a) W is the person's weight in kilograms; and
(b) H is the person's height in metres.
category 1A stressor means one of the following severe traumatic events:
(a) experiencing a life-threatening event;
(b) being subject to a serious physical attack or assault including rape and sexual molestation; or
(c) being threatened with a weapon, being held captive, being kidnapped or being tortured.
category 1B stressor means one of the following severe traumatic events:
(a) killing or maiming a person;
(b) being an eyewitness to a person being killed or critically injured;
(c) being an eyewitness to atrocities inflicted on another person;
(d) participating in the clearance of a corpse or a critically injured casualty; or
(e) viewing a corpse or a critically injured casualty as an eyewitness.
Note: corpse and eyewitness are also defined in the Schedule 1 - Dictionary.
category 2 stressor means one of the following negative life events, the effects of which are chronic in nature and cause the person to feel ongoing distress, concern or worry:
(a) being socially isolated and unable to maintain friendships or family relationships, due to physical location, language barriers, disability, or medical or psychiatric illness;
(b) experiencing a problem with a long-term relationship including the break-up of a close personal relationship, the need for marital or relationship counselling, marital separation or divorce;
(c) having concerns in the work or school environment including ongoing disharmony with fellow work or school colleagues, perceived lack of social support within the work or school environment, perceived lack of control over tasks performed and stressful workloads, or experiencing bullying in the workplace or school environment;
(d) experiencing serious legal issues including being detained or held in custody, ongoing involvement with the police concerning violations of the law, or court appearances associated with personal legal problems;
(e) having severe financial hardship including loss of employment, long periods of unemployment, foreclosure on a property or bankruptcy;
(f) having a family member or significant other experience a major deterioration in their health; or
(g) being a full-time caregiver to a family member or significant other with a severe physical, mental or developmental disability.
Note: significant other is also defined in the Schedule 1 - Dictionary.
chronic renal failure means:
(a) having a glomerular filtration rate of less than 15 mL/min/1.73 m2 for a period of at least 3 months; or
(b) a need for renal replacement therapy (dialysis or transplantation) for treatment of complications of decreased glomerular filtration rate which would otherwise increase the risk of morbidity and mortality; or
(c) undergoing chronic dialysis.
combined oral contraceptive pill as specified means an oral contraceptive pill containing estrogen at a minimum dose of 50 micrograms and a progestogen.
corpse means the human remains or body parts of one or more persons who have met a violent or horrific death.
Note: Examples of a violent or horrific death may include death due to suicide, gunshot, improvised explosive devices, natural and technological disasters, terrorist attacks or motor vehicle accidents. Seeing a closed body bag or viewing a body in an open-casket coffin are excluded from this definition.
eyewitness means a person who experiences an incident first hand and can give direct evidence of it. This excludes persons exposed only to public broadcasting or mass media coverage of the incident.
gingivitis—see subsection 7(2).
irritant substance means a chemical which causes an inflammatory effect on living tissue by chemical action at the site of contact.
Note: Examples of irritant substances include tooth whitening products, dentrifices and mouthwashes.
MRCA means the Military Rehabilitation and Compensation Act 2004.
one pack-year means the amount of tobacco consumed in smoking 20 cigarettes per day for a period of 1 year, or an equivalent amount of tobacco products.
Note 1: An equivalent amount of tobacco products is 7,300 grams of smoking tobacco by weight, either in cigarettes, pipe tobacco or cigars, or a combination of same. For pipe tobacco, cigars or combinations of multiple tobacco types, 1 gram of tobacco is considered to be equal to one cigarette.
Note 2: Pack-years are calculated by dividing the number of cigarettes smoked per day by 20 and multiplying this number by the number of years the person has smoked. For example, smoking 10 cigarettes per day for 10 years is equal to 5 pack-years, and smoking 40 cigarettes per day for 10 years is equal to 20 pack-years.
relevant service means:
(a) operational service under the VEA;
(b) peacekeeping service under the VEA;
(c) hazardous service under the VEA;
(d) British nuclear test defence service under the VEA;
(e) warlike service under the MRCA; or
(f) non-warlike service under the MRCA.
Note: MRCA and VEA are also defined in the Schedule 1 - Dictionary.
severe vitamin C deficiency means symptoms of scurvy or a serum ascorbic acid level of less than 2.5 milligrams per litre.
significant other means a person who has a close family bond or a close personal relationship and is important or influential in one's life.
specified list of autoimmune or mucocutaneous diseases means:
(a) bullous pemphigoid;
(b) chronic ulcerative stomatitis;
(c) dermatomyositis;
(d) discoid lupus erythematosus;
(e) epidermolysis bullosa acquisita;
(f) erythema multiforme;
(g) linear IgA disease;
(h) mixed connective tissue disease;
(i) mucous membrane pemphigoid;
(j) oral lichen planus;
(k) oral lichenoid lesions;
(l) pemphigus vulgaris;
(m) psoriasis;
(n) Sjögren syndrome; or
(o) systemic lupus erythematosus.
terminal event means the proximate or ultimate cause of death and includes the following:
(a) pneumonia;
(b) respiratory failure;
(c) cardiac arrest;
(d) circulatory failure; or
(e) cessation of brain function.
trauma to the affected region of the gums means physical injury to the gingival tissues by various mechanisms including thermal, electrical and chemical burns, abrasion, and blunt or penetrating trauma.
Note: Examples of trauma to the gums include tooth fractures, inappropriate teeth cleaning (including toothbrushing or dental flossing), damage to the gums with sharp instruments and thermal burns from the consumption of hot foods or beverages.
VEA means the Veterans' Entitlements Act 1986.
Note: Endnotes
Note: Endnote 1—About the endnotes
The endnotes provide information about this compilation and the compiled law.
The following endnotes are included in every compilation:
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.
Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.
The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.
The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.
Misdescribed amendments
A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.
If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history.
Note: Endnote 2—Abbreviation key
ad = added or inserted
orig = original
am = amended
par = paragraph(s)/subparagraph(s)
amdt = amendment
/sub‑subparagraph(s)
c = clause(s)
pres = present
C[x] = Compilation No. x
prev = previous
Ch = Chapter(s)
(prev…) = previously
def = definition(s)
Pt = Part(s)
Dict = Dictionary
r = regulation(s)/rule(s)
disallowed = disallowed by Parliament
reloc = relocated
Div = Division(s)
renum = renumbered
exp = expires/expired or ceases/ceased to have
rep = repealed
effect
rs = repealed and substituted
F = Federal Register of Legislation
s = section(s)/subsection(s)
gaz = gazette
Sch = Schedule(s)
LA = Legislation Act 2003
Sdiv = Subdivision(s)
LIA = Legislative Instruments Act 2003
SLI = Select Legislative Instrument
(md not incorp) = misdescribed amendment
SR = Statutory Rules
cannot be given effect
Sub‑Ch = Sub‑Chapter(s)
mod = modified/modification
SubPt = Subpart(s)
No. = Number(s)
underlining = whole or part not
o = order(s)
commenced or to be commenced
Ord = Ordinance
Note: Endnote 3—Legislation history
Name
Registration
Commencement
Application, saving and transitional provisions
Statement of Principles concerning gingivitis (Reasonable Hypothesis) (No. 17 of 2022)
4 January 2022F2022L00010
31 January 2022
Amendment Statement of Principles concerning gingivitis (Reasonable Hypothesis) (No. 115 of 2022)